The export of vaccines for human use from Thailand has shown significant growth from 2013 to 2023, increasing from $3.1038 million to $11.673 million. The year-on-year changes have fluctuated with peaks and troughs, including an exceptional rise of 113.51% in 2017 and a -7.46% decline in 2018. From 2021 to 2023, the growth has been steadier, with a 4.8% increase in 2023. Looking at a longer period, the Compound Annual Growth Rate (CAGR) over the last five years stands at 5.45%, showing consistent performance.
Forecasted data up to 2028 anticipates continued growth, with the value projected to reach $14.241 million by 2028, reflecting a five-year CAGR of 3.01% and a projected 15.99% growth rate from 2023. Future trends to watch include the impact of new vaccine technologies, global health initiatives, and potential new market entries.
